ImmunoINSIGHTS™
A NEW ERA OF IMMUNE BIOMARKERS

We deliver compelling insights powered by our Analytical Engine, ImmunoINSIGHTS™, the leading autoantibody biomarker profiling platform to enable data-driven clinical decisions and advance precision medicine

OUR SERVICES

ImmunoINSIGHTS™ Discovery

ImmunoINSIGHTS™ Disease-Specific Panels

ImmunoINSIGHTS™ Custom Panels


Discover our wide range of panels available across different therapeutic areas:

> Immuno-Oncology
> Autoimmune Diseases
> Infectious Diseases

> CONTACT US

OUR ANALYTICAL ENGINE: ImmunoINSIGHTS™

OncImmune’s end-to-end autoantibody (AAb) platform, the world’s largest human antigen library enables the discovery of clinically relevant biomarker signatures through an array of customized and ready-to-use disease panels.

Why choose ImmunoINSIGHTS™?

> Early disease detection
> Identification of novel target molecules
> Patient stratification & responses to therapy
> Immune-related adverse events (irAEs) prediction

> LEARN MORE

Latest Webinar: The utility of autoantibodies in immuno-oncology -- The better characterisation of the B-Cell antibody repertoire has the potential to provide biomarkers for prediction of clinical reponses and for prediction of immune-related adverse events.
Speaker: Professor Jessica Hassel
ImmunoINSIGHTS On-Demand Webinars
Latest Webinar: The utility of autoantibodies in immuno-oncology -- The better characterisation of the B-Cell antibody repertoire has the potential to provide biomarkers for prediction of clinical reponses and for prediction of immune-related adverse events.
Speaker: Professor Jessica Hassel
ImmunoINSIGHTS On-Demand Webinars

Overview:

The better characterisation of the B-Cell antibody repertoire has the potential to provide biomarkers for prediction of clinical reponses and for prediction of immune-related adverse events.

Speaker: Professor Jessica Hassel

We understand disease through the lens of the human immune system, to enable early detection and better treatment of disease.

See how ImmunoINSIGHTS™ can help your clinical trial programs

Our site uses cookies and other technologies to personalise your experience. Please read our Privacy Policy for more information on the processing of your personal data and how to delete or block the use of cookies. Find out more